2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Gupta Rishi | Director | 7,663,349 | May 20, 2024 |
| Orbimed Advisors Llc | Director | 7,663,349 | May 20, 2024 |
| OrbiMed Genesis GP LLC | Director | 7,663,349 | May 20, 2024 |
| OrbiMed Capital GP VII LLC | Director | 7,663,349 | May 20, 2024 |
| Bonita David P | Director | 4,199,068 | Jun 3, 2022 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Feb 19, 2026 | Heyman Richard A. | Director | Sell | 50.6 | -1,230 | -0.83% | ✓ | $32.2K |
| Feb 17, 2026 | Feb 19, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 8.8 | -45,000 | -64.29% | ✓ | $1.2M |
| Feb 12, 2026 | Feb 17, 2026 | Kunkel Lori Anne | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 12, 2026 | Feb 17, 2026 | Heyman Richard A. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 12, 2026 | Feb 17, 2026 | Gupta Rishi | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 12, 2026 | Feb 17, 2026 | Garland J. Scott | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 12, 2026 | Feb 17, 2026 | Derynck Mika K | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 12, 2026 | Feb 17, 2026 | Bauer Jake | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 12, 2026 | Feb 17, 2026 | Ballal Rahul D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 12, 2026 | Feb 17, 2026 | Patel Anish | COO | Neutral | 85.0 | +20,000 | 9.30% | ✗ | - |
| Feb 12, 2026 | Feb 17, 2026 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Neutral | 82.5 | +18,750 | 2.53% | ✗ | - |
| Feb 12, 2026 | Feb 17, 2026 | Hohl Benjamin | CFO | Neutral | 90.0 | +25,000 | 69.44% | ✗ | - |
| Feb 12, 2026 | Feb 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Neutral | 90.0 | +25,000 | 100.00% | ✗ | - |
| Feb 6, 2026 | Feb 10, 2026 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 48.8 | -5,000 | -0.67% | ✓ | $145.2K |
| Jan 20, 2026 | Jan 22, 2026 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 41.3 | -20,000 | -2.61% | ✓ | $535.1K |
| Jan 20, 2026 | Jan 22, 2026 | Heyman Richard A. | Director | Sell | 50.6 | -1,230 | -0.83% | ✓ | $32.9K |
| Jan 9, 2026 | Jan 13, 2026 | Patel Anish | COO | Sell | 18.8 | -48,300 | -18.34% | ✓ | $1.4M |
| Jan 8, 2026 | Jan 12, 2026 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 23.8 | -132,500 | -14.76% | ✓ | $3.5M |
| Jan 8, 2026 | Jan 12, 2026 | Heyman Richard A. | Director | Sell | 32.5 | -13,920 | -6.40% | ✓ | $348.3K |
| Jan 7, 2026 | Jan 9, 2026 | Garland J. Scott | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 9, 2026 | Garland J. Scott | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 22, 2025 | Dec 23, 2025 | Hohl Benjamin | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 19, 2025 | Dec 23, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 48.8 | -5,000 | -0.55% | ✓ | $84.2K |
| Dec 17, 2025 | Dec 19, 2025 | Kunkel Lori Anne | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 11, 2025 | Dec 12, 2025 | Fair Richard A. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 12, 2025 | Fair Richard A. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 8, 2025 | Dec 10, 2025 | Patel Anish | COO | Sell | 41.3 | -6,663 | -2.47% | ✓ | $140.1K |
| Nov 19, 2025 | Nov 21, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 42.5 | -12,500 | -1.37% | ✓ | $279.2K |
| Nov 17, 2025 | Nov 19, 2025 | Kintz Samuel | CEO | Sell | 42.5 | -12,500 | -1.38% | ✓ | $272.7K |
| Nov 7, 2025 | Nov 12, 2025 | Patel Anish | COO | Sell | 41.3 | -6,667 | -2.41% | ✓ | $116K |
| Oct 20, 2025 | Oct 22, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 42.5 | -12,500 | -1.35% | ✓ | $276K |
| Oct 17, 2025 | Oct 21, 2025 | Kintz Samuel | CEO | Sell | 42.5 | -12,500 | -1.37% | ✓ | $266.7K |
| Oct 7, 2025 | Oct 9, 2025 | Patel Anish | COO | Sell | 41.3 | -6,667 | -2.35% | ✓ | $134K |
| Sep 29, 2025 | Oct 1, 2025 | Hohl Benjamin | CFO | Sell | 25.0 | -3,250 | -12.38% | ✓ | $66.3K |
| Sep 26, 2025 | Sep 30, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 48.8 | -4,000 | -0.43% | ✓ | $81K |
| Sep 26, 2025 | Sep 30, 2025 | Kintz Samuel | CEO | Sell | 48.8 | -3,700 | -0.40% | ✓ | $74.2K |
| Sep 23, 2025 | Sep 25, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 53.8 | -1,500 | -0.16% | ✓ | $30K |
| Sep 23, 2025 | Sep 25, 2025 | Kintz Samuel | CEO | Sell | 48.8 | -2,800 | -0.30% | ✓ | $56.1K |
| Sep 19, 2025 | Sep 23, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 47.5 | -7,000 | -0.74% | ✓ | $135.7K |
| Sep 17, 2025 | Sep 19, 2025 | Kintz Samuel | CEO | Sell | 47.5 | -6,000 | -0.65% | ✓ | $115.7K |
| Sep 8, 2025 | Sep 10, 2025 | Patel Anish | COO | Sell | 41.3 | -6,667 | -2.30% | ✓ | $135K |
| Aug 27, 2025 | Aug 29, 2025 | Hohl Benjamin | CFO | Sell | 25.0 | -3,250 | -12.38% | ✓ | $67K |
| Aug 20, 2025 | Aug 21, 2025 | Kintz Samuel | CEO | Sell | 53.8 | -1,517 | -0.16% | ✓ | $30.3K |
| Aug 19, 2025 | Aug 21, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 45.0 | -12,500 | -1.31% | ✓ | $248.2K |
| Aug 18, 2025 | Aug 20, 2025 | Kintz Samuel | CEO | Sell | 45.0 | -10,983 | -1.17% | ✓ | $219.9K |
| Aug 7, 2025 | Aug 11, 2025 | Patel Anish | COO | Sell | 41.3 | -6,667 | -2.25% | ✓ | $121.6K |
| Jul 28, 2025 | Jul 30, 2025 | Hohl Benjamin | CFO | Sell | 25.0 | -3,250 | -12.38% | ✓ | $66.5K |
| Jul 21, 2025 | Jul 23, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 42.5 | -12,500 | -1.30% | ✓ | $278.6K |
| Jul 17, 2025 | Jul 21, 2025 | Kintz Samuel | CEO | Sell | 42.5 | -12,500 | -1.31% | ✓ | $281.5K |
| Jul 10, 2025 | Jul 14, 2025 | Hohl Benjamin | CFO | Sell | 41.3 | -1,000 | -4.17% | ✓ | $22.7K |
| Jul 7, 2025 | Jul 9, 2025 | Patel Anish | COO | Sell | 41.3 | -6,667 | -2.20% | ✓ | $132K |
| Jun 27, 2025 | Jul 1, 2025 | Hohl Benjamin | CFO | Sell | 25.0 | -3,250 | -12.38% | ✓ | $68K |
| Jun 20, 2025 | Jun 24, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 42.5 | -12,500 | -1.28% | ✓ | $267.5K |
| Jun 17, 2025 | Jun 18, 2025 | Kintz Samuel | CEO | Sell | 42.5 | -12,500 | -1.29% | ✓ | $277.3K |
| Jun 13, 2025 | Jun 17, 2025 | Hohl Benjamin | CFO | Sell | 25.0 | -3,000 | -11.54% | ✓ | $67.7K |
| Jun 9, 2025 | Jun 11, 2025 | Patel Anish | COO | Sell | 41.3 | -6,667 | -2.15% | ✓ | $135.6K |
| Jun 3, 2025 | Jun 5, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 47.5 | -7,500 | -0.76% | ✓ | $150.2K |
| Jun 3, 2025 | Jun 5, 2025 | Kintz Samuel | CEO | Sell | 47.5 | -7,500 | -0.77% | ✓ | $150.4K |
| May 27, 2025 | May 29, 2025 | Hohl Benjamin | CFO | Sell | 25.0 | -3,250 | -12.38% | ✓ | $52.6K |
| May 19, 2025 | May 21, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 47.5 | -5,000 | -0.50% | ✓ | $81.5K |
| May 19, 2025 | May 21, 2025 | Kintz Samuel | CEO | Sell | 47.5 | -5,000 | -0.51% | ✓ | $82.5K |
| May 7, 2025 | May 9, 2025 | Patel Anish | COO | Sell | 41.3 | -6,667 | -2.11% | ✓ | $122.6K |
| May 1, 2025 | May 5, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 47.5 | -7,500 | -0.75% | ✓ | $150.4K |
| May 1, 2025 | May 5, 2025 | Kintz Samuel | CEO | Sell | 47.5 | -7,500 | -0.76% | ✓ | $150.4K |
| Apr 28, 2025 | Apr 30, 2025 | Hohl Benjamin | CFO | Sell | 25.0 | -3,250 | -12.38% | ✓ | $60.7K |
| Apr 21, 2025 | Apr 23, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 48.8 | -5,000 | -0.50% | ✓ | $80.4K |
| Apr 17, 2025 | Apr 21, 2025 | Kintz Samuel | CEO | Sell | 47.5 | -5,000 | -0.50% | ✓ | $82.1K |
| Apr 7, 2025 | Apr 9, 2025 | Patel Anish | COO | Sell | 41.3 | -6,667 | -2.06% | ✓ | $120.3K |
| Mar 27, 2025 | Mar 31, 2025 | Hohl Benjamin | CFO | Sell | 25.0 | -3,250 | -12.38% | ✓ | $69.3K |
| Mar 24, 2025 | Mar 26, 2025 | Hohl Benjamin | CFO | Sell | 41.3 | -1,000 | -4.17% | ✓ | $22.5K |
| Mar 19, 2025 | Mar 21, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 42.5 | -12,500 | -1.23% | ✓ | $257.6K |
| Mar 17, 2025 | Mar 19, 2025 | Kintz Samuel | CEO | Sell | 42.5 | -12,500 | -1.25% | ✓ | $260.3K |
| Mar 7, 2025 | Mar 11, 2025 | Patel Anish | COO | Sell | 41.3 | -6,667 | -2.02% | ✓ | $142.9K |
| Mar 4, 2025 | Mar 6, 2025 | Hohl Benjamin | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 27, 2025 | Mar 3, 2025 | Hohl Benjamin | CFO | Sell | 20.0 | -3,250 | -20.00% | ✓ | $66.3K |
| Feb 6, 2025 | Feb 10, 2025 | Phillips Andrew John | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 6, 2025 | Feb 10, 2025 | Kunkel Lori Anne | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 6, 2025 | Feb 10, 2025 | Heyman Richard A. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 6, 2025 | Feb 10, 2025 | Gupta Rishi | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 6, 2025 | Feb 10, 2025 | Derynck Mika K | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 6, 2025 | Feb 10, 2025 | Bauer Jake | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 6, 2025 | Feb 10, 2025 | Ballal Rahul D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 7, 2025 | Feb 10, 2025 | Patel Anish | COO | Sell | 45.0 | -6,667 | -1.98% | ✓ | $146.2K |
| Feb 6, 2025 | Feb 10, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 6, 2025 | Feb 10, 2025 | Kintz Samuel | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 6, 2025 | Feb 10, 2025 | Hohl Benjamin | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 6, 2025 | Feb 10, 2025 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 5, 2025 | Feb 7, 2025 | Hohl Benjamin | CFO | Sell | 36.3 | -1,000 | -7.14% | ✓ | $22.5K |
| Jan 27, 2025 | Jan 29, 2025 | Hohl Benjamin | CFO | Sell | 20.0 | -3,250 | -20.00% | ✓ | $70.2K |
| Jan 7, 2025 | Jan 10, 2025 | Patel Anish | COO | Sell | 26.3 | -28,367 | -7.77% | ✓ | $685.9K |
| Dec 13, 2024 | Jan 7, 2025 | Hohl Benjamin | CFO | Sell | 36.3 | -1,000 | -7.14% | ✓ | $25K |
| Dec 27, 2024 | Dec 31, 2024 | Hohl Benjamin | CFO | Sell | 10.0 | -4,250 | -100.00% | ✓ | $94.5K |
| Nov 27, 2024 | Dec 2, 2024 | Hohl Benjamin | CFO | Sell | 10.0 | -5,250 | -100.00% | ✓ | $130.7K |
| Oct 28, 2024 | Oct 30, 2024 | Hohl Benjamin | CFO | Sell | 10.0 | -6,250 | -100.00% | ✓ | $178.5K |
| Oct 18, 2024 | Oct 22, 2024 | Patel Anish | COO | Sell | 53.8 | -716 | -0.21% | ✓ | $21.5K |
| Oct 18, 2024 | Oct 22, 2024 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 55.0 | -847 | -0.08% | ✓ | $25.4K |
| Oct 18, 2024 | Oct 22, 2024 | Kintz Samuel | CEO | Sell | 55.0 | -924 | -0.09% | ✓ | $27.7K |
| Oct 18, 2024 | Oct 22, 2024 | Hohl Benjamin | CFO | Sell | 13.8 | -814 | -100.00% | ✓ | $24.4K |
| Oct 18, 2024 | Oct 22, 2024 | Heyman Richard A. | Director | Sell | 48.8 | -1,570 | -1.03% | ✓ | $47.1K |
| Oct 18, 2024 | Oct 22, 2024 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 13.8 | -816 | -100.00% | ✓ | $24.5K |